Utility of bevacizumab in advanced hepatocellular carcinoma: A veterans affairs experience-Reference-Cited by-同舟云学术

Utility of bevacizumab in advanced hepatocellular carcinoma: A veterans affairs experience

Published:2019-02-20 Issue:4 Volume:8 Page:1442-1446
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Med

Author:

Wattenberg Max M.¹^ORCID,Damjanov Nevena¹²,Kaplan David E.³⁴

Affiliation:

1. Division of Hematology‐OncologyPerelman School of MedicineUniversity of Pennsylvania Philadelphia PA, USA

2. Hematology‐Oncology SectionCorporal Michael J. Crescenz VA Medical Center Philadelphia PA, USA

3. Division of Gastroenterology and HepatologyPerelman School of MedicineUniversity of Pennsylvania Philadelphia PA, USA

4. Gastroenterology SectionCorporal Michael J. Crescenz VA Medical Center Philadelphia PA, USA

Funder

National Institutes of Health

Publisher

Wiley

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cam4.2015

Reference18 articles.

1. Cancer Stat Facts: Liver and Intrahepatic Bile Duct Cancer SEER: National Cancer Institute DCCPS Surveillance Research Program;2018https://seer.cancer.gov/statfacts/html/livibd.html.

2. Trends and Patterns of Disparities in Cancer Mortality Among US Counties, 1980-2014

3. Sorafenib in Advanced Hepatocellular Carcinoma

4. Targeted systemic therapies for hepatocellular carcinoma: Clinical perspectives, challenges and implications

5. Phase II Trial Evaluating the Clinical and Biologic Effects of Bevacizumab in Unresectable Hepatocellular Carcinoma

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Place of tyrosine kinase inhibitors in the first line of treatment of hepatocellular carcinoma;Meditsinskiy sovet = Medical Council;2024-01-18

2. Frankincense myrrh attenuates hepatocellular carcinoma by regulating tumor blood vessel development through multiple epidermal growth factor receptor-mediated signaling pathways;World Journal of Gastrointestinal Oncology;2022-02-15

3. Advances in locoregional therapy for hepatocellular carcinoma combined with immunotherapy and targeted therapy;Journal of Interventional Medicine;2021-08

4. Gene Therapy for Hepatocellular Carcinoma: Highlighting the Journey from Theory to Clinical Applications;Advanced Therapeutics;2020-08-13

5. Gd-EOB-DTPA-MRI Could Predict WNT/β-Catenin Mutation and Resistance to Immune Checkpoint Inhibitor Therapy in Hepatocellular Carcinoma;Liver Cancer;2020